Literature DB >> 29395322

Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy.

Jyh Yung Hor1, Thien Thien Lim2, Mei Chih Cheng3, Yuen Kang Chia4, Chee Keong Wong5, Su Min Lim5, Chun Fai Cheah5, Kenny Tan5, P E Samuel Easaw6, M Isabel Leite7.   

Abstract

Thymoma is associated with a wide spectrum of autoimmune paraneoplastic syndromes, though it is uncommon for multiple paraneoplastic syndromes to be present in a single individual. We report a rare case of an elderly gentleman who was found to have thymoma-associated myasthenia gravis and LGI1-encephalitis with myokymia, who presented with nephrotic syndrome (minimal change glomerulopathy) after thymectomy. The latter two paraneoplastic syndromes had manifested when prednisolone was tapered down to low dose. This case serves to remind neurologists that apart from paraneoplastic neurological manifestations, thymoma may also be associated with renal disease. Nephropathy in myasthenia patients with thymoma should be properly evaluated, as it is treatable with immunotherapy, and it may even occur post-thymectomy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  LGI1 encephalitis; Myasthenia; Myokymia; Paraneoplastic syndrome; Thymoma

Mesh:

Substances:

Year:  2018        PMID: 29395322     DOI: 10.1016/j.jneuroim.2018.01.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Remission of Thymoma on Steroid Therapy in a Patient With Atypical Thymoma-Associated Multiorgan Autoimmunity: A Case Report and Literature Review.

Authors:  Ewa Wrona; Sylwia Dębska-Szmich; Marta Pastuszka; Marcin Braun; Rafał Czyżykowski; Piotr Potemski
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

2.  Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report.

Authors:  Qingyang Luo; Xianghong Wu; Wen Huang
Journal:  BMC Neurol       Date:  2019-06-13       Impact factor: 2.474

3.  Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review.

Authors:  Yuou Teng; Ting Li; Zhizhong Yang; Mingwan Su; Jingnian Ni; Mingqing Wei; Jing Shi; Jinzhou Tian
Journal:  Front Neurol       Date:  2022-01-12       Impact factor: 4.003

4.  Thymoma-associated anti-LGI1 encephalitis and myasthenia gravis: A unique combination with autoantibodies.

Authors:  Akane Satake; Takamura Nagasaka; Takafumi Kurita; Hiroaki Murata; Takanori Hata; Hiroyuki Shinmura; Hirochika Matsubara; Kazumasa Shindo; Yoshihisa Takiyama
Journal:  eNeurologicalSci       Date:  2022-03-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.